CoChat

In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus

Menzies, Stefanie K., Clare, Rachel H., Xie, Chunfang, Westhorpe, Adam, Hall, Steven R., Edge, Rebecca J., Alsolaiss, Jaffer, Crittenden, Edouard, Marriott, Amy E., Harrison, Robert A., Kool, Jeroen, Casewell, Nicholas R. · 2022 · Toxicon: X
Cited by 46

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.toxcx.2022.100118

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 51

  1. Ainsworth, 2018, The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms, Commun. Biol., 1, 1, 10.1038/s42003-018-0039-1 · DOI
  2. Albulescu, 2020, Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite, Sci. Transl. Med., 12, 10.1126/scitranslmed.aay8314 · DOI · Paper page
  3. Albulescu, 2020, A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite, Nat. Commun., 11, 6094, 10.1038/s41467-020-19981-6 · DOI · Paper page
  4. Alomran, 2021, Pathology-specific experimental antivenoms for haemotoxic snakebite: the impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms, PLoS Negl. Trop. Dis., 15, 10.1371/journal.pntd.0009659 · DOI
  5. Arias, 2017, Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom, Toxicon Off. J. Int. Soc. Toxinol., 132, 40, 10.1016/j.toxicon.2017.04.001 · DOI · Paper page
  6. Berling, 2015, Hematologic effects and complications of snake envenoming, Transfus. Med. Rev., 29, 82, 10.1016/j.tmrv.2014.09.005 · DOI · Paper page
  7. Bittenbinder, 2018, Coagulotoxic cobras: clinical implications of strong anticoagulant actions of African spitting Naja venoms that are not neutralised by antivenom but are by LY315920 (varespladib), Toxins, 10, 516, 10.3390/toxins10120516 · DOI · Paper page
  8. Bryan-Quirós, 2019, Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2, Toxicon, 157, 1, 10.1016/j.toxicon.2018.11.292 · DOI · Paper page
  9. Bulfone, 2018, Developing small molecule therapeutics for the initial and adjunctive treatment of snakebite, J. Trop. Med., 2018, 1, 10.1155/2018/4320175 · DOI · Paper page
  10. Casewell, 2010, Pre-clinical assays predict Pan-African Echis viper efficacy for a species-specific antivenom, PLoS Negl. Trop. Dis., 4, 10.1371/journal.pntd.0000851 · DOI · Paper page
  11. Chowdhury, 2021, Venom-induced blood disturbances by palearctic viperid snakes, and their relative neutralization by antivenoms and enzyme-inhibitors, Front. Immunol., 12, 688802, 10.3389/fimmu.2021.688802 · DOI
  12. Chowdhury, 2021, The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of African spitting cobra (Naja species) venoms, Front. Immunol., 12, 10.3389/fimmu.2021.752442 · DOI · Paper page
  13. Clare, 2021, Small molecule drug discovery for neglected tropical snakebite, Trends Pharmacol. Sci., 42, 340, 10.1016/j.tips.2021.02.005 · DOI · Paper page
  14. de Silva, 2016, Adverse reactions to snake antivenom, and their prevention and treatment, Br. J. Clin. Pharmacol., 81, 446, 10.1111/bcp.12739 · DOI · Paper page
  15. Debono, 2017, Coagulating colubrids: evolutionary, pathophysiological and biodiscovery implications of venom variations between boomslang (Dispholidus typus) and twig snake (Thelotornis mossambicanus), Toxins, 9, 171, 10.3390/toxins9050171 · doi:10.3390/toxins9050171
  16. Debono, 2020, The sweet side of venom: glycosylated prothrombin activating metalloproteases from Dispholidus typus (boomslang) and Thelotornis mossambicanus (twig snake), Comp. Biochem. Physiol. C Toxicol. Pharmacol., 227, 108625, 10.1016/j.cbpc.2019.108625 · DOI
  17. Gomperts, 1977, Laboratory studies and clinical features in a case of boomslang envenomation, South Afr. Med. J. Suid-Afr Tydskr Vir Geneeskd., 51, 173
  18. Gutiérrez, 2006, Confronting the neglected problem of snake bite envenoming: the need for a global partnership, PLoS Med., 3, 10.1371/journal.pmed.0030150 · DOI · Paper page
  19. Gutiérrez, 2017, Preclinical evaluation of the efficacy of antivenoms for snakebite envenoming: state-of-the-art and challenges ahead, Toxins, 9, 163, 10.3390/toxins9050163 · DOI
  20. Gutiérrez, 2021, The search for natural and synthetic inhibitors that would complement antivenoms as therapeutics for snakebite envenoming, Toxins, 13, 451, 10.3390/toxins13070451 · DOI · Paper page
  21. Halilu, 2019, Snakebite burden in Sub-Saharan Africa: estimates from 41 countries, Toxicon, 159, 1, 10.1016/j.toxicon.2018.12.002 · DOI
  22. Harrison, 2019, The time is now: a call for action to translate recent momentum on tackling tropical snakebite into sustained benefit for victims, Trans. R. Soc. Trop. Med. Hyg., 113, 835, 10.1093/trstmh/try134 · DOI
  23. Howes, 2007, Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators, Toxicon Off. J. Int. Soc. Toxinol., 49, 734, 10.1016/j.toxicon.2006.11.020 · DOI
  24. Kamiguti, 2000, Mass spectrophotometric evidence for P-III/P-IV metalloproteinases in the venom of the Boomslang (Dispholidus typus), Toxicon, 38, 1613, 10.1016/S0041-0101(00)00089-1 · doi:10.1016/s0041-0101(00)00089-1
  25. Kazandjian, 2021, Anticoagulant activity of Naja nigricollis venom is mediated by phospholipase A2 toxins and inhibited by varespladib, Toxins, 13, 302, 10.3390/toxins13050302 · DOI
  26. Kini, 2018, Biosynthetic Oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims, Toxins, 10, 534, 10.3390/toxins10120534 · DOI
  27. Knudsen, 2019, Engineering and design considerations for next-generation snakebite antivenoms, Toxicon Off. J. Int. Soc. Toxinol., 167, 67, 10.1016/j.toxicon.2019.06.005 · DOI
  28. Knudsen, 2020, Novel snakebite therapeutics must Be tested in appropriate rescue models to robustly assess their preclinical efficacy, Toxins, 12, 528, 10.3390/toxins12090528 · DOI
  29. Krüger, 2019, Fatal boomslang bite in the northern cape, Afr. J. Emerg. Med., 9, 53, 10.1016/j.afjem.2018.12.006 · doi:10.1016/j.afjem.2018.12.006
  30. Lakier, 1969, Consumptive coagulopathy caused by a boomslang bite, South Afr. Med. J. Suid-Afr Tydskr Vir Geneeskd., 43, 1052
  31. Layfield, 2020, Repurposing cancer drugs batimastat and marimastat to inhibit the activity of a group I metalloprotease from the venom of the western diamondback rattlesnake, Crotalus atrox. Toxins., 12, 309, 10.3390/toxins12050309 · DOI · Paper page
  32. Lewin, 2016, Varespladib (LY315920) appears to Be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation, Toxins, 8, 248, 10.3390/toxins8090248 · DOI · Paper page
  33. Lewin, 2018, Delayed oral LY333013 rescues mice from highly neurotoxic, lethal doses of papuan Taipan (Oxyuranus scutellatus) venom, Toxins, 10, 380, 10.3390/toxins10100380 · DOI · Paper page
  34. Lewin, 2018, Delayed LY333013 (oral) and LY315920 (intravenous) reverse severe neurotoxicity and rescue Juvenile pigs from lethal doses of Micrurus fulvius (Eastern coral snake) venom, Toxins, 10, 10.3390/toxins10110479 · DOI · Paper page
  35. Liu, 2021, Snake venom proteome of Protobothrops mucrosquamatus in Taiwan: delaying venom-induced lethality in a rodent model by inhibition of phospholipase A2 activity with varespladib, J. Proteonomics, 234, 104084, 10.1016/j.jprot.2020.104084 · DOI
  36. Longbottom, 2018, Vulnerability to snakebite envenoming: a global mapping of hotspots, Lancet, 392, 673, 10.1016/S0140-6736(18)31224-8 · DOI · Paper page
  37. Matell, 1973, Consumption coagulopathy caused by a boomslang bite: a case report, Thromb. Res., 3, 173, 10.1016/0049-3848(73)90067-4 · doi:10.1016/0049-3848(73)90067-4
  38. Pla, 2017, What killed Karl Patterson Schmidt? Combined venom gland transcriptomic, venomic and antivenomic analysis of the South African green tree snake (the boomslang), Dispholidus typus, Biochim. Biophys. Acta Gen. Subj., 1861, 814, 10.1016/j.bbagen.2017.01.020 · DOI
  39. Potet, 2019, Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial, PLoS Negl. Trop. Dis., 13, 10.1371/journal.pntd.0007551 · DOI
  40. Rucavado A, Escalante T, Franceschi A, et al. Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa EDTA. Am. J. Trop. Med. Hyg. 63. Published online 2000. · DOI · Paper page
  41. Sanhajariya, 2018, Pharmacokinetics of snake venom, Toxins, 10, 73, 10.3390/toxins10020073 · DOI · Paper page
  42. Seneci, 2021, A clot twist: extreme variation in coagulotoxicity mechanisms in Mexican neotropical rattlesnake venoms, Front. Immunol., 12, 612846, 10.3389/fimmu.2021.612846 · doi:10.3389/fimmu.2021.612846
  43. Slagboom, 2020, High throughput screening and identification of coagulopathic snake venom proteins and peptides using nanofractionation and proteomics approaches, PLoS Negl. Trop. Dis., 14, 10.1371/journal.pntd.0007802 · DOI
  44. Still, 2017, Multipurpose HTS coagulation analysis: assay development and assessment of coagulopathic snake venoms, Toxins, 9, 10.3390/toxins9120382 · DOI
  45. Wang, 2018, Exploration of the inhibitory potential of varespladib for snakebite envenomation, Molecules, 23, 391, 10.3390/molecules23020391 · DOI · Paper page
  46. Warrell, 1977, Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria, Q. J. Med., 46, 33
  47. Williams, 2019, The urgent need to develop novel strategies for the diagnosis and treatment of snakebites, Toxins, 11, 10.3390/toxins11060363 · DOI
  48. Xie, 2020, Neutralizing effects of small molecule inhibitors and metal chelators on coagulopathic Viperinae snake venom toxins, Biomedicines, 8, 297, 10.3390/biomedicines8090297 · DOI
  49. Xie, 2020, Neutralising effects of small molecule toxin inhibitors on nanofractionated coagulopathic Crotalinae snake venoms, Acta Pharm. Sin. B, 10, 1835, 10.1016/j.apsb.2020.09.005 · DOI · Paper page
  50. Youngman, 2020, Varespladib (LY315920) neutralises phospholipase A2 mediated prothrombinase-inhibition induced by Bitis snake venoms, Comp. Biochem. Physiol. C Toxicol. Pharmacol., 236, 108818, 10.1016/j.cbpc.2020.108818 · DOI
  51. Zietek, 2018, Liquid chromatographic nanofractionation with parallel mass spectrometric detection for the screening of plasmin inhibitors and (metallo)proteinases in snake venoms, Anal. Bioanal. Chem., 410, 5751, 10.1007/s00216-018-1253-x · DOI

Cited by

See all 46

Metadata

Authors
Menzies, S. K., Clare, R. H., Xie, C., Westhorpe, A., Hall, S. R., Edge, R. J., Alsolaiss, J., Crittenden, E., Marriott, A. E., Harrison, R. A., Kool, J., & Casewell, N. R.
Venue
Toxicon: X
Publisher
Elsevier BV
Published
2022-06
Volume
14
Pages
100118
ISSN
2590-1710
Cited by
46
References
1
Language
en
Licence
Funders
  • Liverpool School of Tropical Medicine
  • China Scholarship Council (201706250035)
  • Wellcome Trust (221712/Z/20/Z, 204806/Z/16/Z)
  • The Royal Society
  • Medical Research Council (MR/S00016X/1, 200517/Z/16/Z)
  • Commonwealth Scholarship Commission
  • University of Liverpool

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus. https://app.cochat.ai/papers/10.1016/j.toxcx.2022.100118
The paper
Menzies, S. K., Clare, R. H., Xie, C., Westhorpe, A., Hall, S. R., Edge, R. J., Alsolaiss, J., Crittenden, E., Marriott, A. E., Harrison, R. A., Kool, J., & Casewell, N. R. (2022). In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus. Toxicon: X. https://doi.org/10.1016/j.toxcx.2022.100118

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.